Skip to content

The Effect of Flexible Tape in Knee Osteoarthritis

The Effect of Flexible Tape Versus Placebo Tape in Patients Completing a Home Exercise Program With Knee Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02049216
Acronym
FTKOA
Enrollment
36
Registered
2014-01-30
Start date
2014-08-31
Completion date
2016-10-31
Last updated
2017-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

knee, osteoarthritis, tape, exercise, rocktape

Brief summary

People with osteoarthritis (OA) of the knee attending The Alfred hospital will be invited to participate in a randomised controlled trial comparing two different types of knee taping. Both groups will also be prescribed an exercise program to assist in management of their knee OA. Hypothesis are as follows: 1. Participants treated with flexible tape with have greater reductions in pain and improvements on timed performance based measures when compared to those treated with a placebo tape. 2. Participants in both groups will have clinically significant improvements in pain and timed performance based measures compared to their baseline scores.

Detailed description

Interventions: Participants in both groups will attend physiotherapy on 4 occasions, in addition to an initial appointment where baseline data will be collected. All participants will be provided with an individualised home exercise program. This will be provided based on the investigators' clinical experience and evidence based programs. The participant will be provided with a handout detailing the exercises they are to complete, including dosage. If there is excessive pain or difficulty associated with completing an exercise the participant will be advised to cease that particular exercise until they have been reviewed by the researcher the following week. Participants will have their knee taped according to either the therapeutic flexible taping protocol, or the placebo taping protocol depending on which group they have been randomly allocated to on three occasions at one week intervals. All participants will be provided with written information regarding tape allergies and when to remove the tape from their knee. To control for the Hawthorne effect participants will not be aware of whether they are in the intervention or placebo group. Participants will attend for appointments once per week for three weeks. They will then have a three week period of no intervention and return for a review and completion of the study. At this time the participant can be referred for further physiotherapy intervention as is clinically indicated. This may include physiotherapy at The Alfred Hospital, private practice or the participants' local health services. If at anytime a participant wishes to withdraw from the study they can be referred by the investigators to continue their physiotherapy in the appropriate setting. Sample size calculations: The investigators hypothesise that the combination of taping and an exercise program will give rise to clinically significant improvements in functional capacity, symptoms and quality of life. If there is truly no difference in the change in VAS between placebo and therapeutic based groups, then 30 patients are required to be 90% sure that the 95% confidence interval will exclude a difference in means of more than 20mm. This has been demonstrated by Tubach and colleagues in 2005. This assumes a standard deviation of the change in VAS of 21.5. Due to participant attrition anticipated an additional 20% will be recruited to the sample. This will total 36 participants in total. Feasibility: The osteoarthritis hip and knee clinic at The Alfred hospital review approximately 13 patients per week of which the majority would be appropriate for inclusion in this trial. There are also many referrals from orthopaedics, rheumatology and emergency for patients who will be appropriate for inclusion. It is therefore anticipated that recruitment to the study will not be a barrier to completion of this trial. Statistical analysis: All data will be analysed by intention to treat. Continuous variables will be analysed using analysis of covariance, controlling for baseline values and recruitment centre. The proportion of participants who complete the program will be compared between groups using a chi-squared test and the relative risk of non-completion will be determined. Alpha will be set at 0.05

Interventions

OTHERFlexible tape

Flexible, elasticised, adhesive athletic tape

OTHERFixomull
OTHERExercise

Participants in both groups will be prescribed a home exercise program to complete.

Sponsors

The Alfred
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of osteoarthritis of the knee * radiological diagnosis of osteoarthritis of the knee * able to understand basic English * knee outcome and injury scale available in patients's preferred language

Exclusion criteria

* other significant lower limb pathology * previous total knee replacement in effected knee * co-morbidities limiting participation in a basic home exercise program or performance of outcome measures eg. unstable cardiac or respiratory conditions

Design outcomes

Primary

MeasureTime frameDescription
Change in pain on visual analogue scalebaseline, 0,3 and 6 weeks after commencement of intervention• Pain on a Visual Analogue Scale (VAS) over last 48hrs at rest and movement. Anchors used will be no pain and worst imaginable pain. The VAS has been found to be valid, reliable and sensitive to change in this population (Tubach et al, 2005)

Secondary

MeasureTime frameDescription
Chang in Knee injury and osteoarthritis outcome score (excluding sport domain)baseline, one week, three weeks and six weeksThe KOOS, a valid and reliable functional questionnaire in patients with knee conditions covering the domains of function, symptoms, quality of life and sport . Sport will not be included in analysis as this is not relevant to the study population.

Other

MeasureTime frameDescription
Change in time to complete 40m walk testbaseline, 1 week from baseline with no intervention (control period), immediately after the first tape application (one week), three weeks and six weeksA fast-paced walking test that is timed over 4 x 10m (33 ft) for a total 40 m (132 ft) as per protocol available at: http://www.oarsi.org/sites/default/files/docs/2013/manual.pdf
Change in pain on visual analogue scale (VAS) during 30 sec sit to stand testprior to initial knee taping and 30mins later following knee tapeOnce 30sec sit to stand is completed participants to rate pain on VAS
Change in 30 sec STS testbaseline, 1 week from baseline with no intervention (control period), immediately after the first tape application (one week), three weeks and six weeksThe maximum number of chair stand repetitions possible in a 30 second period as per protocol available at: http://www.oarsi.org/sites/default/files/docs/2013/manual.pdf
Change in pain on visual analogue scale (VAS) 3 stair climb testprior to initial knee taping and 30mins later following knee tapeOnce 3 stair climb test is completed participants to rate pain on VAS
Change in amount of weekly analgesia medication consumedweekly for 4 weeksParticipants will be asked to keep a record of the number of tablets they take per week for pain relief. This will be compared within each particiapnt over the first four weeks of the study period.
Change in pain on visual analogue scale (VAS) 40m walk testprior to initial knee taping and 30mins later following knee tapeOnce 40m walk test is completed participants to rate pain on VAS
Change in time taken to climb 3 stepsbaseline, 1 week from baseline with no intervention (control period), immediately after the first tape application (one week), three weeks and six weeksThe time (in seconds) it takes to ascend and descend a 3 stairs as per protocol available at: http://www.oarsi.org/sites/default/files/docs/2013/manual.pdf

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026